|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02160 MP CARDIOFLOW-B
Nominal 
1.620 -0.050 (-2.994%) | 2025/12 - Final USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | (3,318) | (15,397) | (29,238) | (26,206) | (25,335) |
| Net Cash from / (used in) Investing Activities | 51,925 | (112,000) | (84,198) | (25,811) | (68,629) |
| Net Cash from / (used in) Financing Activities | 5,696 | (7,919) | (3,617) | (19,586) | 349,271 |
| Increase / (Decrease) in Cash & Cash Equivalents | 54,303 | (135,316) | (117,054) | (71,602) | 255,306 |
| Cash & Cash Equivalents at beginning of period | 15,028 | 150,378 | 263,634 | 317,511 | 96,082 |
| Effect of Foreign Exchange Rate Changes | 237 | (34) | 3,873 | 22,036 | (4,449) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 69,568 | 15,028 | 150,453 | 267,945 | 346,939 |
| Remarks: | Real time quote last updated: 04/06/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -18,819 |
| %Change | 170.855% |
| EPS / (LPS) | USD -0.040 |
| NBV Per Share ($) | USD 0.201 |